logo-loader

AEON Biopharma

Receive alerts
Market:
PRIVATE
Market Cap:
-
Price
-
Change
-
52 weeks high
-
52 weeks low
-

In brief

AEON Biopharma is breaking new ground as the only company solely dedicated to the medical applications of toxins. Our ABP450 therapeutic toxin is the first 900 kDa toxin innovation in the US in 30 years, offering new hope to patients suffering from disabling disorders.